![](/img/cover-not-exists.png)
Docetaxel plus cetuximab biweekly is an active regimen for the first-line treatment of patients with recurrent/metastatic head and neck cancer
Posch, Doris, Fuchs, Hannah, Kornek, Gabriela, Grah, Anja, Pammer, Johannes, Aretin, Marie-Bernadette, Fuereder, ThorstenVolume:
6
Language:
english
Journal:
Scientific Reports
DOI:
10.1038/srep32946
Date:
December, 2016
File:
PDF, 346 KB
english, 2016